Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1

31 Jan 2013

Abstract excerpt

Human immunodeficiency virus type 1 (HIV-1) vaccine development requires selection of appropriate envelope (Env) immunogens. Twenty HIV-1 Env glycoproteins were examined for their ability to bind human anti-HIV-1 monoclonal antibodies (MAbs) and then used as immunogens in guinea pigs to identify promising immunogens. These included five Envs derived from chronically infected individuals, each representing one of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV Research and Treatment
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23365441
DOI: 10.1128/jvi.02297-12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1PMID 23365441Read ↗

Breadth of Neutralizing Antibodies Elicited by Stable, Homogeneous Clade A and Clade C HIV-1 gp140 Envelope Trimers in Guinea PigsSemantic proximity Read ↗

Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.Semantic proximity Read ↗

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Semantic proximity Read ↗

Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infectionSemantic proximity Read ↗

HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.Semantic proximity Read ↗

A Multivalent Clade C HIV-1 Env Trimer Cocktail Elicits a Higher Magnitude of Neutralizing Antibodies than Any Individual ComponentSemantic proximity Read ↗

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.Semantic proximity Read ↗

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialSemantic proximity Read ↗

Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope GlycoproteinsSemantic proximity Read ↗

Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.Semantic proximity Read ↗

Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C InfectionSemantic proximity Read ↗

Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular <i>env</i> Clones from Acute and Early Heterosexually Acquired Infections in Southern AfricaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.